Skip to main content
SpringerLink
Log in
Book cover

Kidney Transplant Management pp 103–111Cite as

Post Kidney Transplant: Hypertension

  • Chapter
  • First Online:

  • 978 Accesses

Abstract

Hypertension is common among kidney transplant recipients. Uncontrolled blood pressure in the kidney transplant recipients is associated with increased cardiovascular mortality and morbidity, and decreased graft survival. The Kidney Disease: Improving Global Outcomes (KDIGO) and American Society of Transplantation (AST) guidelines recommended a target blood pressure ≤130/80 in kidney transplant recipients. In this book chapter, we reviewed the available evidence based on randomized clinical trials and large observational studies in kidney transplant recipients. Based on the available data, it can be concluded: (a) a blood pressure target of ≤130/80 is a reasonable goal as suggested by KDIGO; (b) the choice of antihypertensive agent should be based on the patients’ other comorbidities; and (c) achieving good blood pressure control is more important than the choice of the antihypertensive agent.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Available from: https://www.usrds.org/2012/view/default.aspx.

  2. Rigatto C, Foley R, Jeffery J, Negrijn C, Tribula C, Parfrey P. Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia. J Am Soc Nephrol. 2003;14(2):462–8.

    Article  Google Scholar 

  3. Kasiske BL, Anjum S, Shah R, Skogen J, Kandaswamy C, Danielson B, et al. Hypertension after kidney transplantation. Am J Kidney Dis. 2004;43(6):1071–81.

    Article  Google Scholar 

  4. Opelz G, Dohler B, Collaborative Transplant S. Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant. 2005;5(11):2725–31.

    Article  Google Scholar 

  5. Campistol JM, Romero R, Paul J, Gutierrez-Dalmau A. Epidemiology of arterial hypertension in renal transplant patients: changes over the last decade. Nephrol Dial Transplant. 2004;19(Suppl 3):iii62–6.

    PubMed  Google Scholar 

  6. Paoletti E, Gherzi M, Amidone M, Massarino F, Cannella G. Association of arterial hypertension with renal target organ damage in kidney transplant recipients: the predictive role of ambulatory blood pressure monitoring. Transplantation. 2009;87(12):1864–9.

    Article  Google Scholar 

  7. Karthikeyan V, Karpinski J, Nair RC, Knoll G. The burden of chronic kidney disease in renal transplant recipients. Am J Transplant. 2004;4(2):262–9.

    Article  Google Scholar 

  8. Modena FM, Hostetter TH, Salahudeen AK, Najarian JS, Matas AJ, Rosenberg ME. Progression of kidney disease in chronic renal transplant rejection. Transplantation. 1991;52(2):239–44.

    Article  CAS  Google Scholar 

  9. Guidi E, Menghetti D, Milani S, Montagnino G, Palazzi P, Bianchi G. Hypertension may be transplanted with the kidney in humans: a long-term historical prospective follow-up of recipients grafted with kidneys coming from donors with or without hypertension in their families. J Am Soc Nephrol. 1996;7(8):1131–8.

    CAS  PubMed  Google Scholar 

  10. Prasad GV, Ruzicka M, Burns KD, Tobe SW, Lebel M. Hypertension in dialysis and kidney transplant patients. Can J Cardiol. 2009;25(5):309–14.

    Article  Google Scholar 

  11. Blanca L, Jimenez T, Cabello M, Sola E, Gutierrez C, Burgos D, et al. Cardiovascular risk in recipients with kidney transplants from expanded criteria donors. Transplant Proc. 2012;44(9):2579–81.

    Article  CAS  Google Scholar 

  12. Weir MR, Burgess ED, Cooper JE, Fenves AZ, Goldsmith D, McKay D, et al. Assessment and management of hypertension in transplant patients. J Am Soc Nephrol. 2015;26(6):1248–60.

    Article  CAS  Google Scholar 

  13. Bruno S, Remuzzi G, Ruggenenti P. Transplant renal artery stenosis. J Am Soc Nephrol. 2004;15(1):134–41.

    Article  Google Scholar 

  14. Hoorn EJ, Hesselink DA, Kho MM, Roodnat JI, Weimar W, van Saase JL, et al. A case of primary aldosteronism revealed after renal transplantation. Nat Rev Nephrol. 2011;7(1):55–60.

    Article  Google Scholar 

  15. Molnar MZ, Lazar AS, Lindner A, Fornadi K, Czira ME, Dunai A, et al. Sleep apnea is associated with cardiovascular risk factors among kidney transplant patients. Clin J Am Soc Nephrol. 2010;5(1):125–32.

    Article  Google Scholar 

  16. Veenstra DL, Best JH, Hornberger J, Sullivan SD, Hricik DE. Incidence and long-term cost of steroid-related side effects after renal transplantation. Am J Kidney Dis. 1999;33(5):829–39.

    Article  CAS  Google Scholar 

  17. Mangray M, Vella JP. Hypertension after kidney transplant. Am J Kidney Dis. 2011;57(2):331–41.

    Article  CAS  Google Scholar 

  18. Vincenti F, Schena FP, Paraskevas S, Hauser IA, Walker RG, Grinyo J, et al. A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients. Am J Transplant. 2008;8(2):307–16.

    Article  CAS  Google Scholar 

  19. Bartholomeusz B, Hardy KJ, Nelson AS, Phillips PA. Modulation of nitric oxide improves cyclosporin A-induced hypertension in rats and primates. J Hum Hypertens. 1998;12(12):839–44.

    Article  CAS  Google Scholar 

  20. Farge D, Julien J. Effects of transplantation on the renin angiotensin system (RAS). J Hum Hypertens. 1998;12(12):827–32.

    Article  CAS  Google Scholar 

  21. Zhang R, Leslie B, Boudreaux JP, Frey D, Reisin E. Hypertension after kidney transplantation: impact, pathogenesis and therapy. Am J Med Sci. 2003;325(4):202–8.

    Article  Google Scholar 

  22. Sander M, Lyson T, Thomas GD, Victor RG. Sympathetic neural mechanisms of cyclosporine-induced hypertension. Am J Hypertens. 1996;9(11):121S–38S.

    Article  CAS  Google Scholar 

  23. Hoorn EJ, Walsh SB, McCormick JA, Furstenberg A, Yang CL, Roeschel T, et al. The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension. Nat Med. 2011;17(10):1304–9.

    Article  CAS  Google Scholar 

  24. Dragun D, Muller DN, Brasen JH, Fritsche L, Nieminen-Kelha M, Dechend R, et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med. 2005;352(6):558–69.

    Article  CAS  Google Scholar 

  25. Reddy VS, Guleria S, Abdullah SM, Bansal R. A kink in transplantation: a rare cause of early graft dysfunction. Saudi J Kidney Dis Transpl. 2013;24(5):965–8.

    Article  Google Scholar 

  26. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, et al. Cardiovascular prognosis of “masked hypertension” detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004;291(11):1342–9.

    Article  CAS  Google Scholar 

  27. Haydar AA, Covic A, Jayawardene S, Agharazii M, Smith E, Gordon I, et al. Insights from ambulatory blood pressure monitoring: diagnosis of hypertension and diurnal blood pressure in renal transplant recipients. Transplantation. 2004;77(6):849–53.

    Article  Google Scholar 

  28. Wadei HM, Amer H, Griffin MD, Taler SJ, Stegall MD, Textor SC. Abnormal circadian blood pressure pattern 1-year after kidney transplantation is associated with subsequent lower glomerular filtration rate in recipients without rejection. J Am Soc Hypertens. 2011;5(1):39–47.

    Article  Google Scholar 

  29. van Riemsdijk IC, Mulder PG, de Fijter JW, Bruijn JA, van Hooff JP, Hoitsma AJ, et al. Addition of isradipine (Lomir) results in a better renal function after kidney transplantation: a double-blind, randomized, placebo-controlled, multi-center study. Transplantation. 2000;70(1):122–6.

    PubMed  Google Scholar 

  30. Martinez-Castelao A, Hueso M, Sanz V, Rejas J, Alsina J, Grinyo JM. Treatment of hypertension after renal transplantation: long-term efficacy of verapamil, enalapril, and doxazosin. Kidney Int Suppl. 1998;68:S130–4.

    Article  CAS  Google Scholar 

  31. de Mattos AM, Olyaei AJ, Bennett WM. Pharmacology of immunosuppressive medications used in renal diseases and transplantation. Am J Kidney Dis. 1996;28(5):631–67.

    Article  Google Scholar 

  32. Guan D, Wang R, Lu J, Wang M, Xu C. Effects of nicardipine on blood cyclosporine levels in renal transplant patients. Transplant Proc. 1996;28(3):1311–2.

    CAS  PubMed  Google Scholar 

  33. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Lancet. 1997;349(9069):1857–63.

    Google Scholar 

  34. Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, et al. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA. 2001;285(21):2719–28.

    Article  CAS  Google Scholar 

  35. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345(12):861–9.

    CAS  Google Scholar 

  36. Philipp T, Martinez F, Geiger H, Moulin B, Mourad G, Schmieder R, et al. Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET. Nephrol Dial Transplant. 2010;25(3):967–76.

    Article  CAS  Google Scholar 

  37. Knoll GA, Fergusson D, Chasse M, Hebert P, Wells G, Tibbles LA, et al. Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial. Lancet Diabetes Endocrinol. 2016;4(4):318–26.

    Article  CAS  Google Scholar 

  38. Ibrahim HN, Jackson S, Connaire J, Matas A, Ney A, Najafian B, et al. Angiotensin II blockade in kidney transplant recipients. J Am Soc Nephrol. 2013;24(2):320–7.

    Article  CAS  Google Scholar 

  39. Hiremath S, Fergusson DA, Fergusson N, Bennett A, Knoll GA. Renin-angiotensin system blockade and long-term clinical outcomes in kidney transplant recipients: a meta-analysis of randomized controlled trials. Am J Kidney Dis. 2017;69(1):78–86.

    Article  CAS  Google Scholar 

  40. Taber DJ, Srinivas TM, Pilch NA, Meadows HB, Fleming JN, McGillicuddy JW, et al. Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients. Am J Nephrol. 2013;38(4):285–91.

    Article  CAS  Google Scholar 

  41. Ponticelli C, Cucchiari D, Graziani G. Hypertension in kidney transplant recipients. Transpl Int. 2011;24(6):523–33.

    Article  Google Scholar 

  42. Moes AD, Hesselink DA, van den Meiracker AH, Zietse R, Hoorn EJ. Chlorthalidone versus amlodipine for hypertension in kidney transplant recipients treated with tacrolimus: a randomized crossover trial. Am J Kidney Dis. 2017;69(6):796–804.

    Article  CAS  Google Scholar 

  43. Huysmans FT, van Heusden FH, Wetzels JF, Hoitsma AJ, Koene RA. Antihypertensive effect of beta blockade in renal transplant recipients with or without host kidneys. Transplantation. 1988;46(2):234–7.

    Article  CAS  Google Scholar 

  44. Suwelack B, Kobelt V, Erfmann M, Hausberg M, Gerhardt U, Rahn KH, et al. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients. Transpl Int. 2003;16(5):313–20.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nephrology and Hypertension Specialists, Florissant, MO, USA

    Vikram Patney

  2. Department of Medicine, Division of Nephrology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

    Fahad Aziz

Authors
  1. Vikram Patney
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fahad Aziz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fahad Aziz .

Editor information

Editors and Affiliations

  1. Department of Medicine, Division of Nephrology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

    Sandesh Parajuli

  2. Department of Medicine, Division of Nephrology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

    Fahad Aziz

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Patney, V., Aziz, F. (2019). Post Kidney Transplant: Hypertension. In: Parajuli, S., Aziz, F. (eds) Kidney Transplant Management. Springer, Cham. https://doi.org/10.1007/978-3-030-00132-2_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-00132-2_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-00131-5

  • Online ISBN: 978-3-030-00132-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation